CVS is making plans to increase stores with extra fitness offerings to 10 extra markets. CVS HealthHub places consist of health offerings to control persistent diseases and extra fitness-targeted merchandise like blood-testing gadgets and sleep apnea machines. The expansion plans are scheduled for the primary half of 2020. (CNBC)
Reckitt Benckiser will pay $1.Four billion to give up opioid probes. The Justice Department changed into investigating whether or not former RB subsidiary Indivior did an unlawful scheme to boost sales of opioid addiction treatment. It is the biggest opioid-associated agreement up to now. (Reuters)
The house committee weighs legalizing marijuana. Members of the House Judiciary Subcommittee on Crime, Terrorism, and Homeland Security discussed decriminalizing and legalizing pot on the federal level. Eleven states have legalized recreational marijuana use for adults. (CNBC)
Most Americans help to make cigarettes much less addictive. Eighty-one percent of Americans have said they assist adjustments to make cigarettes with much less nicotine, in line with data from the Centers for Disease Control and Prevention. In 2010, most effective approximately 1/2 supported cigarettes with much less nicotine. (Time)
The White House has pulled its thought to end drug rebates. The ban could have compelled pharmacy to gain managers to bypass rebates to sufferers instead of maintaining the difference as profit. Shares of PBMs, drug distributors, and insurers jumped after the statement. (MM&M)
Five things for pharma entrepreneurs to recognize: Thursday, July eleven, 2019
Federal Reserve Chairman Jerome Powell stated the opioid crisis has had a “quite good-sized” impact at the U.S. Economic system. Powell said on Wednesday that it had affected exertions-force participation, which has held at about 63% for the past five years. (CNBC)
GlaxoSmithKline has employed Kim Branson to oversee its synthetic intelligence crew. Branson formerly labored at Roche’s Genentech unit in San Francisco. The hire is a part of GSK’s purpose of overhauling its studies and improve operations. (Bloomberg)
A new California law will permit low-income adults age 25 and younger to be eligible for Medicaid, although they’re no longer felony residents. Governor Gavin Newsom signed the invoice on Tuesday, making California the first nation to offer health benefits to individuals regardless of immigration repute. The law is anticipated to cost taxpayers $ ninety-eight million. (NBC News)
Amazon is partnering with the U.K.’s National Health Service to provide health statistics to Alexa customers. The voice assistance technology will pull records from the NHS internet site while users ask health-associated questions. (CNBC)
Going to sky-diving? On holiday at the seashore along with your own family? Or simply putting out at home together with your pet? Snap an image of or take a selfie with the MM&M issue to reveal to us where you read the magazine. Use the hashtag #MMMWishYouWereHere for the risk to be featured in MM&M.
Five things for pharma marketers to recognize: Wednesday, July 10, 2019
A decision in Oklahoma has denied Johnson & Johnson’s movement to dismiss the nation’s case accusing it of contributing to the opioid epidemic. J&J has stated the lawsuit is making it a “scapegoat” for the public fitness disaster. Purdue Pharma and Teva Pharmaceuticals have both settled with the kingdom. (CNN)
A federal decision struck down the guideline requiring drugmakers to reveal list expenses in TV commercials just hours earlier than presupposed to move into effect. The judge stated the Department of Health and Human Services did now not have the authority to make the guideline. (MM&M)
Novartis is making plans to sell its universal epinephrine shot in pharmacies amid the EpiPen scarcity. There has been a scarcity of EpiPen, made using Mylan, for extra than 12 months because of production troubles. A surge in demand for the pictures commonly occurs in the summertime as mother and father put together to send youngsters with allergic reactions returned to high school. (Reuters)
A lawsuit that would determine the fate of the Affordable Care Act has commenced the appeals method. The case becomes appealed after a Texas federal decides struck down the complete healthcare regulation in December. It could make its manner to the Supreme Court earlier than the 2020 election. (New York Times)
